Fundraising FoxBlue Heron Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
VIDA provides AI-powered imaging biomarkers and clinical trial imaging services, using its VIDA Intelligence Platform to collect and analyze imaging data across respiratory, cardiovascular, oncology, and other therapeutic areas.
AI & Machine LearningHealthtechMedical DevicesCoralville, US
Susan A. Wood(Executive Officer, Director)inSusan Wood(Chief Executive Officer)inSandra Stapleton(Chief Operating Officer)inTodd Johnson(Chief Technology Officer)inLars Nordenmark(Chief Scientific Officer)in
BoardRobert Bozeman(Director)
Co-investorsFirst AnalysisRittenhouse VenturesChartline Capital PartnersNext Level Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.